View in EDS HTML Full Text PDF Full Text

Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters.

Saved in:
Bibliographic Details
Title: Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters.
Authors: Zaeck LM; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands., Tan NH; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands., Rietdijk WJR; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands., Geers D; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands., Sablerolles RSG; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands., Bogers S; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands., van Dijk LLA; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands., Gommers L; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands., van Leeuwen LPM; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands., Rugebregt S; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands., Goorhuis A; Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, Amsterdam, the Netherlands.; Infection and Immunity, Amsterdam Public Health, University of Amsterdam, Amsterdam, the Netherlands., Postma DF; Department of Internal Medicine and Infectious Diseases, University Medical Center Groningen, Groningen, the Netherlands., Visser LG; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands., Dalm VASH; Department of Internal Medicine, Division of Allergy and Clinical Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands., Lafeber M; Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., Kootstra NA; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Immunology and Infectious Diseases, University of Amsterdam, Amsterdam, the Netherlands., Huckriede ALW; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Haagmans BL; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands., van Baarle D; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands., Koopmans MPG; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands., van der Kuy PHM; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands., GeurtsvanKessel CH; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands. c.geurtsvankessel@erasmusmc.nl., de Vries RD; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.
Corporate Authors: SWITCH-ON Research Group
Source: Nature communications [Nat Commun] 2024 May 18; Vol. 15 (1), pp. 4224. Date of Electronic Publication: 2024 May 18.
Publication Type: Journal Article; Randomized Controlled Trial
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38762522
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zaeck+LM%22">Zaeck LM</searchLink>; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Tan+NH%22">Tan NH</searchLink>; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Rietdijk+WJR%22">Rietdijk WJR</searchLink>; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Geers+D%22">Geers D</searchLink>; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Sablerolles+RSG%22">Sablerolles RSG</searchLink>; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Bogers+S%22">Bogers S</searchLink>; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Dijk+LLA%22">van Dijk LLA</searchLink>; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Gommers+L%22">Gommers L</searchLink>; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Leeuwen+LPM%22">van Leeuwen LPM</searchLink>; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Rugebregt+S%22">Rugebregt S</searchLink>; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Goorhuis+A%22">Goorhuis A</searchLink>; Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Amsterdam University Medical Centers, Amsterdam, the Netherlands.; Infection and Immunity, Amsterdam Public Health, University of Amsterdam, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Postma+DF%22">Postma DF</searchLink>; Department of Internal Medicine and Infectious Diseases, University Medical Center Groningen, Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Visser+LG%22">Visser LG</searchLink>; Department of Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Dalm+VASH%22">Dalm VASH</searchLink>; Department of Internal Medicine, Division of Allergy and Clinical Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands.; Department of Immunology, Erasmus University Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Lafeber+M%22">Lafeber M</searchLink>; Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Kootstra+NA%22">Kootstra NA</searchLink>; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam Institute for Immunology and Infectious Diseases, University of Amsterdam, Amsterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Huckriede+ALW%22">Huckriede ALW</searchLink>; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Haagmans+BL%22">Haagmans BL</searchLink>; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Baarle+D%22">van Baarle D</searchLink>; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Koopmans+MPG%22">Koopmans MPG</searchLink>; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22van+der+Kuy+PHM%22">van der Kuy PHM</searchLink>; Department of Hospital Pharmacy, Erasmus University Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22GeurtsvanKessel+CH%22">GeurtsvanKessel CH</searchLink>; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands. c.geurtsvankessel@erasmusmc.nl.<br /><searchLink fieldCode="AU" term="%22de+Vries+RD%22">de Vries RD</searchLink>; Department of Viroscience, Erasmus University Medical Center, Rotterdam, the Netherlands.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22SWITCH-ON+Research+Group%22">SWITCH-ON Research Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2024 May 18; Vol. 15 (1), pp. 4224. <i>Date of Electronic Publication: </i>2024 May 18.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38762522
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-024-48414-x
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 4224
    Titles:
      – TitleFull: Original COVID-19 priming regimen impacts the immunogenicity of bivalent BA.1 and BA.5 boosters.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zaeck LM
      – PersonEntity:
          Name:
            NameFull: Tan NH
      – PersonEntity:
          Name:
            NameFull: Rietdijk WJR
      – PersonEntity:
          Name:
            NameFull: Geers D
      – PersonEntity:
          Name:
            NameFull: Sablerolles RSG
      – PersonEntity:
          Name:
            NameFull: Bogers S
      – PersonEntity:
          Name:
            NameFull: van Dijk LLA
      – PersonEntity:
          Name:
            NameFull: Gommers L
      – PersonEntity:
          Name:
            NameFull: van Leeuwen LPM
      – PersonEntity:
          Name:
            NameFull: Rugebregt S
      – PersonEntity:
          Name:
            NameFull: Goorhuis A
      – PersonEntity:
          Name:
            NameFull: Postma DF
      – PersonEntity:
          Name:
            NameFull: Visser LG
      – PersonEntity:
          Name:
            NameFull: Dalm VASH
      – PersonEntity:
          Name:
            NameFull: Lafeber M
      – PersonEntity:
          Name:
            NameFull: Kootstra NA
      – PersonEntity:
          Name:
            NameFull: Huckriede ALW
      – PersonEntity:
          Name:
            NameFull: Haagmans BL
      – PersonEntity:
          Name:
            NameFull: van Baarle D
      – PersonEntity:
          Name:
            NameFull: Koopmans MPG
      – PersonEntity:
          Name:
            NameFull: van der Kuy PHM
      – PersonEntity:
          Name:
            NameFull: GeurtsvanKessel CH
      – PersonEntity:
          Name:
            NameFull: de Vries RD
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 18
              M: 05
              Text: 2024 May 18
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 15
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1